Weinmann
Weinmann is a 90-year-old clinical laboratory and diagnostic brand in Rio Grande do Sul, Brazil, operating 22+ units under Grupo Fleury. It serves individual patients and 158 health insurers with lab tests, genetic testing, imaging (Serdil), and vaccines.
- Company typePrivate
- Founded1930
- HeadquartersJabaquara, Brazil
- Headcount5,001–10,000
- GTM typeB2C
- OfferingServices
What Weinmann does
Weinmann is a regional clinical laboratory and diagnostic medicine brand headquartered in Porto Alegre, Rio Grande do Sul, Brazil, founded in 1930 and operating for more than 90 years. It runs more than 22 service units across Porto Alegre and its metropolitan region (including Canoas, Cachoeirinha, Caxias do Sul), offering laboratory testing (over 53 exam types), genetic testing (NIPT, CGH-SNP Array, Exome, Oncotype DX), diagnostic imaging through the Serdil unit (MRI, CT, mammography, bone densitometry, digital radiology, ultrasound), and a portfolio of vaccines for all age groups. The technology stack is anchored by Sysmex automated hematology analyzers (XE2100, XT2000, XS1000i, XT1800, XN, XE5000) and Cellavision digital morphology for blood analysis, with advanced genomic testing delivered via an exclusive partnership with Fleury Genômica.
The business model is predominantly business-to-consumer with a sales-led motion targeting individual patients and health insurance holders; 158 health insurance plans are accepted, and a freemium 'Pra Você Card' discount program serves uninsured private-pay patients. Revenue is generated through health insurance billing, out-of-pocket exam and vaccine payments, and a virtual vaccine store. Distribution is multi-channel: physical units, a home collection service (Coleta Domiciliar) covering 11 municipalities, an iOS/Android mobile app, an e-commerce vaccine storefront, and a health insurance partner network. Weinmann also holds Quality Certifications from the Colégio Brasileiro de Radiologia / Associação Médica Brasileira and was named the leading laboratory in the 2026 'Marcas de Quem Decide' ranking.
Weinmann is a wholly-owned operating brand of Fleury S.A. (B3:FLEURY3), one of Brazil's largest publicly traded diagnostic medicine companies, part of the Grupo Fleury network. As a subsidiary brand, Weinmann benefits from the parent group's scale, technology partnerships, and capital allocation, while operating with a regionally autonomous commercial focus on Rio Grande do Sul. The company is led operationally by a technical responsible (Kátia Zanotelli Fassina, CRM 23034-RS) and functions as a stable, mature regional franchise rather than an independent growth-stage venture.
Weinmann firmographics
Firmographics- Name
- Weinmann
- Legal name
- Fleury S.A.
- Website
- https://weinmann.com.br
- Company type
- Private
- Founded year
- 1930
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- Weinmann is a 90-year-old clinical laboratory and diagnostic brand in Rio Grande do Sul, Brazil, operating 22+ units under Grupo Fleury. It serves individual patients and 158 health insurers with lab tests, genetic testing, imaging (Serdil), and vaccines.
- Ownership category
- akta.pro rank
Weinmann industry classification
Industry- Product category
- Diagnostic Laboratory Services
- NAICS
- Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- At-Home Lab Testing & Diagnostics-Integrated Virtual Care (HLALAAAE)
- akta.pro secondary industry
- Lab Draws, Specimen Collection & Point-of-Care Testing (In-Home) (HSABACAN)
Keywords
Where Weinmann is headquartered
LocationHeadquarters
- HQ city
- Jabaquara
- HQ country
- Brazil
- HQ region
- Latin America
Offices9 records
Markets served
Weinmann business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales
Revenue model
- Laboratory Testing Services: Clinical analysis laboratory services including blood tests, urinalysis, genetic tests, and toxicology exams. Revenue generated through health insurance billing and private payments.
- Vaccine Sales: Sale of vaccines including influenza, dengue, and specialized vaccines for different age groups. Direct sales through units and virtual store.
- Private Patient Services: Discount program (Pra Você Card) offering reduced prices on laboratory and imaging exams for uninsured patients. Free card with access to affordable pricing.
- Diagnostic Imaging Services: Imaging services including MRI, CT scan, mammography, bone densitometry, digital radiology, and ultrasound at Serdil unit.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Dengue vaccine at R$ 442.00 |
| Unit Pricing | Pay-as-you-go | Influenza (Gripe) vaccine at R$ 100.00 |
| Freemium | Pay-as-you-go | Pra Você Card discount program - free membership |
Go-to-market motion2 records
Distribution channels6 records
Marketing channels6 records
Weinmann product offering
Product offeringCore offering
Weinmann operates a network of clinical analysis laboratories offering blood tests, urinalysis, toxicology screening, genetic testing, and vaccine administration, complemented by the Serdil diagnostic imaging unit providing MRI, CT scan, mammography, bone densitometry, digital radiology, and ultrasound services. Customers access services through 22+ physical units across Porto Alegre and the metropolitan region, via a mobile phlebotomy home collection service, or by purchasing vaccines through an online virtual store, with digital results delivered through the Weinmann Serdil mobile app. The company serves insured patients via 158 health plans and uninsured patients via the Pra Você Card discount program.
Product overview
Weinmann is a clinical laboratory and diagnostic services company operating as part of Grupo Fleury, offering a comprehensive portfolio of laboratory tests, vaccines, genetic testing, and diagnostic imaging services. The core offering consists of the Weinmann laboratory brand (reference in clinical analyses in Rio Grande do Sul for over 90 years), the Serdil diagnostic imaging clinic (50 years of tradition in radiology, MRI, CT, mammography), and genetic testing services (NIPT, CGH Array, Exome Sequencing, Oncotype DX). Additional services include home collection, a vaccine portfolio, and a mobile app. The company operates 22+ units in Porto Alegre and metropolitan region, serving 158+ insurance providers.
Differentiator
Problem solved
Functional benefit
Products and services
- Weinmann Clinical Laboratory (Laboratório Weinmann) Core clinical laboratory brand offering laboratory tests, vaccines, and diagnostics; serves insured patients, private patients, and physicians across Porto Alegre and metropolitan region as part of Grupo Fleury.
- Serdil Diagnostic Imaging Specialized diagnostic imaging brand offering MRI, CT scan, mammography, bone densitometry, digital radiology, and ultrasound with Doppler; holds Quality Certifications from the Colégio Brasileiro de Radiologia and serves patients with 49 years of tradition.
- Genetic Testing (Testes Genéticos) Genetic testing services provided through the exclusive Fleury Genômica platform, including NIPT, CGH Array, Exome Sequencing, and Oncotype DX for diagnosis, prognosis, and treatment guidance. Sample collection available at Weinmann units or at home.
- NIPT and NIPT Ampliado (Non-Invasive Prenatal Test) Non-invasive prenatal test performed from a maternal blood sample to evaluate fetal risk for Down, Edwards, and Patau syndromes; available from the 10th week of gestation.
- CGH-SNP Array Postnatal genetic test capable of identifying genome alterations to aid diagnosis of developmental disorders including autism, congenital malformations, and epilepsy.
- Exome Sequencing (Sequenciamento do Exoma) High-complexity test that searches for genetic alterations causing distinct conditions through evaluation of all human genes, with applications in neurology, hematology, and medical genetics.
- Oncotype DX Molecular diagnostic test that analyzes the individual biology of a malignant tumor to assist in selecting the best treatment for tumors.
- Home Collection Service (Coleta Domiciliar) Mobile phlebotomy service for at-home sample collection for exams and vaccines, covering Porto Alegre, Canoas, Cachoeirinha, Gravataí, Viamão, Esteio, Sapucaia do Sul, São Leopoldo, Novo Hamburgo, Eldorado do Sul, Guaíba, and Alvorada; offered at no additional cost during promotional periods.
- Vaccines (Vacinas) Comprehensive vaccine portfolio including influenza (gripe) at R$100, dengue at R$442, and high-dose flu vaccine for seniors 60+, with categories for pregnant women, babies, children, adolescents, adults, and seniors; available at units and through the virtual vaccine store.
- Weinmann Serdil Mobile App Mobile application for accessing test results, scheduling appointments, and managing healthcare services, available on iOS and Android.
Quantifiable outcome
- 90+ years of laboratory excellence in Rio Grande do Sul
- +3 more outcomes
Companies that use Weinmann
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles4 records
Weinmann technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Weinmann partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- Fleury GenômicacoreExclusive partnership for genetic testing services. Weinmann offers Fleury Genômica's online platform for tests including NIPT, CGH Array, Exome sequencing, and Oncotype DX. Sample collection available at Weinmann units or at home.
- Colégio Brasileiro de Radiologia - Associação Médica BrasileiracoreSerdil unit holds Quality Certifications from the Brazilian College of Radiology - Medical Association of Brazil, demonstrating compliance with professional standards in radiology and diagnostic imaging.
- 158 Health Insurance ProviderscoreNetwork of 158 health insurance plans accepted at Weinmann units, allowing covered patients to access laboratory, imaging, and vaccine services through their insurance plans.
- Fleury S.A. (Parent Company)coreWeinmann is part of Grupo Fleury, one of Brazil's leading diagnostic medicine companies. Fleury S.A. (CNPJ: 60.840.055/0001-31) is headquartered in São Paulo.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
Weinmann competitors and assessment
Company assessmentDirect peers
- Sabin Group: Brazilian diagnostic laboratory chain operating across multiple states with similar DTC lab services. Directly comparable to Weinmann in business model, customer base, and product offering.
- CDB Diagnósticos: Brazilian diagnostic imaging and laboratory network. Comparable to Weinmann/Serdil in providing combined laboratory and imaging services with similar patient-facing operational model.
- Hermes Pardini: One of Brazil's largest clinical laboratory chains offering comprehensive testing services. Comparable to Weinmann in scale, multi-state operations, and breadth of test portfolio including specialty diagnostics.
- Pasteur Medicina Diagnóstica: Brazilian diagnostic laboratory chain with comprehensive testing services. Comparable to Weinmann in lab services model, multi-unit operation, and customer segmentation across individual patients and health plans.
- Delboni Auriemo: Brazilian clinical laboratory and diagnostic imaging network, part of Dasa. Comparable to Weinmann in offering combined laboratory and imaging services under a single brand.
- Allmed: Brazilian occupational health and diagnostic services company. Comparable to Weinmann in providing diagnostic testing to both individuals and corporate clients with similar B2B/B2C hybrid model.
- Sérgio Franco: Brazilian diagnostic laboratory chain in Rio de Janeiro, part of Dasa. Comparable to Weinmann in multi-unit clinical laboratory operations, comprehensive testing portfolio, and consumer-facing service model.
Regional players
- Biolabor: Smaller Brazilian diagnostic laboratory chain. Comparable to Weinmann in DTC laboratory services but at smaller scale and operating primarily in different regional markets.
- Ativa Diagnósticos: Brazilian regional diagnostic medicine company with comparable lab and imaging services. Operates in different geography from Weinmann but with similar product offerings and target market.
Broad incumbents
- Dasa: Brazil's largest diagnostic medicine company operating multiple lab brands (Sérgio Franco, Delboni Auriemo, etc.) across Brazil. Larger incumbent with overlapping capabilities but much broader geographic and service portfolio than Weinmann.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks4 records
Key highlights7 records
Customer concentration
Weinmann social profiles
Digital presenceWeinmann financial estimates
Financial estimateRevenue estimate
Valuation estimate
Weinmann leadership team
Management profileNumber of profiles
Profiles1 record
Weinmann subsidiaries and ownership
Company hierarchySubsidiaries2 records
Weinmann funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Weinmann M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Weinmann
What does Weinmann do?
Weinmann operates a network of clinical analysis laboratories offering blood tests, urinalysis, toxicology screening, genetic testing, and vaccine administration, complemented by the Serdil diagnostic imaging unit providing MRI, CT scan, mammography, bone densitometry, digital radiology, and ultrasound services. Customers access services through 22+ physical units across Porto Alegre and the metropolitan region, via a mobile phlebotomy home collection service, or by purchasing vaccines through an online virtual store, with digital results delivered through the Weinmann Serdil mobile app. The company serves insured patients via 158 health plans and uninsured patients via the Pra Você Card discount program.
Is Weinmann a public or private company?
Weinmann is a private company. It is classified as corporate owned and is currently operating.
When was Weinmann founded?
Weinmann was founded in 1930. It employs 5,001 to 10,000 people.
Where is Weinmann based?
Weinmann is headquartered in Jabaquara, Brazil, in the Latin America region.
How does Weinmann make money?
Four revenue lines are on record. Laboratory Testing Services are the primary driver. The others are vaccine Sales, private Patient Services and diagnostic Imaging Services.
Who are Weinmann's main competitors?
Direct peers on record are Sabin Group, CDB Diagnósticos, Hermes Pardini, Pasteur Medicina Diagnóstica, Delboni Auriemo, Allmed and Sérgio Franco. Regional players are Biolabor and Ativa Diagnósticos. Dasa is listed as a broad incumbent.
Does Weinmann have an API?
No public API is recorded for Weinmann.
What industry is Weinmann in?
Weinmann's product category is Diagnostic Laboratory Services. Its primary akta.pro industry code is HLALAAAE, At-Home Lab Testing & Diagnostics-Integrated Virtual Care, with a secondary code of HSABACAN, Lab Draws, Specimen Collection & Point-of-Care Testing (In-Home). Its NAICS code is 62151 and its SIC code is 8071.